Nachman said there was a lack of "visibility on the generic pipeline, where we believe TEVA is behind its peers." He also said it was too soon to call a bottom in U.S. generics.
Headquartered in Petach Tikva, Israel, the pharmaceutical company's shares were trading at $15.61, down 2.41% on Thursday.
How Much Money Will I Need to Retire?
Want to learn about retirement planning from some of the nation's top experts? Join TheStreet's Robert "Mr. Retirement" Powell live in New York on April 6 for our Retirement Strategies Symposium. For a limited time, tickets are available for $99 for this full-day event. Check out the agenda, learn about the speakers and sign up here.